Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Express Scripts
Moodys
Johnson and Johnson
McKesson

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Details for Biologics License Application: 125126

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for BLA: 125126
Tradename:GARDASIL
Applicant:Merck Sharp & Dohme Corp.
Ingredient:human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant
Patents:5
Approval Date:Jun 08, 2006
Suppliers: see list1

US Patents for BLA: 125126

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. GARDASIL human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant INJECTION, SUSPENSION 125126 001 2006-06-08   Start Trial Chevron Phillips Chemical Company LP (The Woodlands, TX) 2031-06-06 search
Merck Sharp & Dohme Corp. GARDASIL human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant INJECTION, SUSPENSION 125126 001 2006-06-08   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2033-03-11 search
Merck Sharp & Dohme Corp. GARDASIL human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant INJECTION, SUSPENSION 125126 001 2006-06-08   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2029-05-13 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Express Scripts
Mallinckrodt
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.